Aegon N.V.

Major Shareholding Notification • Oct 17, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	State Street Global Advisors & Affiliates
Company dealt in	AbbVie Inc.
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.01 common stock
Date of dealing	16th October 2019

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	68,610,686	4.63956%
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	68,610,686	4.63956%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (Note 5)
Purchase	10,100	74.75
Purchase	200	74.75
Purchase	4,100	74.75
Purchase	3,013	74.94
Purchase	52	74.75
Purchase	1,770	74.75
Purchase	244	74.75
Purchase	8,870	74.75
Purchase	49,450	74.75
Purchase	396	74.75
Purchase	102	74.75
Purchase	180	74.75
Purchase	1,318	74.75
Purchase	1,301	74.75
Sale	4,400	74.75
Sale	4,100	74.75
Sale	255	74.75
Sale	10,100	74.75
Sale	200	74.75
Sale	300	74.75
Sale	43,463	74.75
Sale	226	74.75
Sale	22,464	74.75
Sale	4,200	74.75
Sale	50	74.75

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)
N/A

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing  varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
N/A

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)
N/A

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)
N/A

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
N/A

Is a Supplemental Form 8 attached? (Note 9)	NO
Date of disclosure	17th October 2019
Contact name	Lionel Colaco
Telephone number	020 33956098
If a connected EFM, name of offeree/offeror with which connected	N/A
If a connected EFM, state nature of connection (Note 10)	N/A